Table of Contents

1 Study Coverage

• 1.1 Pets Parasiticide Medicines Revenue in Pets Parasiticide Medicines Business (2017-2022) & (US$ Million) Introduction
• 1.2 Global Pets Parasiticide Medicines Outlook 2017 VS 2022 VS 2028
• 1.2.1 Global Pets Parasiticide Medicines Market Size for the Year 2017-2028

2 Pets Parasiticide Medicines by Type

• 2.1 Pets Parasiticide Medicines Market Segment by Type
• 2.1.1 In Vitro Parasiticide Medicines

3 Pets Parasiticide Medicines by Application

• 3.1 Pets Parasiticide Medicines Market Segment by Application
• 3.1.1 Dogs

4 Global Pets Parasiticide Medicines Competitor Landscape by Company

• 4.1 Global Pets Parasiticide Medicines Market Size by Company
• 4.1.1 Top Global Pets Parasiticide Medicines Companies Ranked by Revenue (2021)

5 Global Pets Parasiticide Medicines Market Size by Region

• 5.1 Global Pets Parasiticide Medicines Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Pets Parasiticide Medicines Market Size by Region (2017-2028)
• 5.2.1 Global Pets Parasiticide Medicines Market Size by Region: 2017-2022

6 Segment in Region Level & Country Level

• 6.1 North America
• 6.1.1 North America Pets Parasiticide Medicines Market Size YoY Growth 2017-2028

7 Company Profiles

• 7.1 Boehringer Ingelheim
• 7.1.1 Boehringer Ingelheim Company Details

8 Research Findings and Conclusion

9 Appendix

• 9.1 Research Methodology
• 9.1.1 Methodology/Research Approach

Summary:

Market Analysis and Insights: Global and United States Pets Parasiticide Medicines Market

This report focuses on global and United States Pets Parasiticide Medicines market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Pets Parasiticide Medicines market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, In Vitro Parasiticide Medicines accounting for % of the Pets Parasiticide Medicines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Dogs was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Pets Parasiticide Medicines market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Pets Parasiticide Medicines Scope and Market Size

Pets Parasiticide Medicines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pets Parasiticide Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Pets Parasiticide Medicines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Pets Parasiticide Medicines market is segmented into

In Vitro Parasiticide Medicines

In Vivo Parasiticide Medicines

Segment by Application, the Pets Parasiticide Medicines market is segmented into

Dogs

Cats

Equine

Others

Regional and Country-level Analysis

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Pets Parasiticide Medicines Market Share Analysis

Pets Parasiticide Medicines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Pets Parasiticide Medicines business, the date to enter into the Pets Parasiticide Medicines market, Revenue in Pets Parasiticide Medicines Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:

Boehringer Ingelheim

Zoetis

Elanco

Bayer

Merck

Vetoquinol

Bimeda Animal Health

Virbac

Ceva Sante Animale